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Rios v. Bayer: The Illinois Supreme Court Recognizes Bristol-Myers
Squibb
Jamison Winters
I.

Introduction

In Madison County, Illinois, lawsuits are commonplace. In 2019, 4,062
asbestos-related lawsuits were filed in the United States.1 Of those, 1,150, or
28.3%, were filed in Madison County, easily making it the top jurisdiction
for asbestos litigation.2 In contrast, St. Clair County, Illinois, immediately
south of Madison County, ranked in at a not-so-close second place for
asbestos litigation, with 9% of all asbestos-related lawsuits nationwide filed
there in 2019.3 Further, of the plaintiffs who filed asbestos lawsuits in
Illinois, only 8% resided in the state.4 These statistics, coupled with the fact
that the average asbestos lawsuit names a whopping sixty-five defendants,5
are enough to raise the eyebrows of anyone with an elementary
understanding of personal jurisdiction.
This excessive use of the tort system is not new to Madison County and is
not limited to the asbestos docket. Over the years the county has garnered
a reputation as America’s preeminent “judicial hellhole,” a “jackpot
jurisdiction,” a “local slot machine,” “lawyer heaven,” and an “asbestos
mecca.”6 Madison County’s tort system abuse problem is so well-known
that George W. Bush traveled to the county to give a speech on tort reform
in early 2005.7 Abuse of class certification in class action lawsuits, uniquely
successful welding rod litigation, and medical malpractice claims that
literally drove physicians out of the county are just a few additional
 J.D. Candidate, 2022, Saint Louis University School of Law
1 Asbestos Litigation: 2019 Year in Review, KCIC 3 (2020),
https://www.kcic.com/media/2059/kcic-2019-asbestos-report.pdf.
2 Id. at 5–6.
3 Id.
4 Id. at 12.
5 Id. at 11.
6 Victor E. Schwartz et al., Asbestos Litigation in Madison County, Illinois: The Challenge
Ahead, 16 WASH. U. J.L. & POL'Y 235, 235–36, 243 (2004).
7 President Bush Visits Collinsville to Discuss Tort Reform, ST. LOUIS BUSINESS JOURNAL (Jan.
5, 2005), https://www.bizjournals.com/stlouis/stories/2005/01/03/daily37.html.
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examples of tort system abuse in the county.8 Madison County was also the
origin of the famous Philip Morris cigarette case, in which the trial judge
awarded the plaintiffs’ attorneys a hefty $1.78 billion in fees.9 To say the
least, Madison County is an attractive option to forum shoppers.
II.

Bristol-Myers Squibb

Over the past decade, the Supreme Court has decided several cases related
to personal jurisdiction,10 and these cases have done much to discourage
forum shopping.11 The case most relevant to defendants facing lawsuits
from nonresident plaintiffs in the Madison County courthouse is BristolMyers Squibb Co. v. Superior Court of California, San Francisco County,12
wherein the Court dismissed hundreds of nonresident plaintiffs from a
mass tort lawsuit.13 The Court restated the requirement that, in order for a
court to exercise jurisdiction, the plaintiff’s claims must “arise out of” or
“relate to” the defendant’s contacts with the forum state,14 and the case has
largely been regarded as narrowing that requirement.15
III.

Rios v. Bayer

In 2016 and 2017, two mass tort actions were filed in the circuit court of
Madison County against pharmaceutical giant Bayer for injuries related to
Bayer’s Essure device.16 The two suits involved 180 plaintiffs from at least
twenty-five different states.17 Citing recently-decided Bristol-Myers Squibb,
Schwartz, supra note 6, at 239–244.
Vanessa O’Connell, Illinois Judge Orders Philip Morris To Pay $10.1 Billion in Damages,
WALL ST. J. (Mar. 24, 2003), https://www.wsj.com/articles/SB104829437457872000.
10 See e.g., Goodyear Dunlop Tires Operations, S.A. v. Brown, 564 U.S. 915 (2011); Daimler
AG v. Bauman, 571 U.S. 117 (2014); Walden v. Fiore, 571 U.S. 277 (2014).
11 See generally Howard M. Erichson et al., Case-Linked Jurisdiction and Busybody States, 105
MINN. L. REV. HEADNOTES (forthcoming 2020).
12 137 S. Ct. 1773.
13 Id. at 1777.
14 Id. at 1780.
15 See, e.g., Megan Crowe, Can You Relate? Bristol-Myers Narrowed the Relatedness
Requirement but Changed Little in the Specific Jurisdiction Analysis, 63 ST. LOUIS U. L.J. 505,
514 (2019) (“The Court’s holding [in Bristol-Myers Squibb] demonstrated an attempt to
narrow the scope of the relatedness requirement.”).
16 Rios v. Bayer Corp., Nos. 125020 & 125021, 2020 WL 2963318, at *1 (Ill. Jun. 4, 2020).
17 Id.
8
9
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Bayer filed motions to dismiss the nonresident plaintiffs for lack of personal
jurisdiction.18 The circuit court of Madison County denied the motions to
dismiss, and Bayer sought an interlocutory appeal.19 After the appellate
court affirmed the circuit court of Madison County, the cases were
consolidated and went up to the Illinois Supreme Court.20
Plaintiffs argued that the circuit court had jurisdiction over Bayer because
it conducted clinical trials for Essure, created a training program for
physicians related to Essure, and developed a marketing campaign for
Essure, all in Illinois.21 At the outset of its analysis, the court recognized the
distinction in personal jurisdiction between general and specific jurisdiction
and found that general jurisdiction was not at issue.22 Citing Bristol-Myers
Squibb, the court further recognized that specific jurisdiction requires the
defendant to purposefully avail itself of contacts in the forum state and that
the plaintiff’s claims must “arise out of” or “relate to” the defendant’s
contacts.23
Bayer admitted to having purposefully directed activities at Illinois.24 It did
not dispute that it had conducted clinical trials, organized a physician
training program, and created a marketing campaign, all related to its
Essure device, in Illinois.25 However, Bayer argued, and the court ultimately
held, that the plaintiffs’ claims did not “arise out of” or “relate to” Bayer’s
activities in Illinois.26 Plaintiffs, for example, alleged defects in Bayer’s
manufacturing of Essure, but Essure was manufactured in California,
Mexico, and Costa Rica — not Illinois.27 Similarly, Plaintiffs alleged Bayer
“willfully disseminated false and misleading information” about Essure,
but the nonresident plaintiffs did not allege that they received false
information about Essure in Illinois.28
Id.
Id. at *2.
20 Id. at *3.
21 Rios, 2020 WL 2963318, at *4.
22 Id.
23 Id.
24 Id. at *5.
25 Id.
26 Rios, 2020 WL 2963318, at *5.
27 Id.
28 Id.
18
19
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“In short,” the court held, “the nonresident plaintiffs have identified no
jurisdictionally relevant links between their claims and Illinois.”29 The court
went on to acknowledge that, following Bristol-Myers Squibb, the United
States District Court for the Eastern District of Missouri had dismissed
hundreds of nonresident plaintiffs from mass tort lawsuits related to Essure
across the river in St. Louis on the same grounds. 30 Finally, because the
nonresident plaintiffs had not articulated a reason why Illinois could be a
convenient location to litigate their claims when they were not implanted
with or sold Essure in the state, and because Illinois “has no particular
interest in resolving claims that did not arise out of or relate to activities
that occurred” in the state, the court concluded that allowing the
nonresidents plaintiffs’ claims to proceed in Illinois would be
unreasonable.31
IV.

Conclusion

The Illinois Supreme Court’s recognition of Bristol-Myers Squibb in Rios is a
victory, not only for defendants being sued in Madison County by plaintiffs
who do not reside in the state, but also for Illinois residents, who are forced
to endure the negative economic effects of tort system abuse.32 Although at
least one expert has speculated that not much is likely to change in Madison
County,33 Rios could potentially be used to dismiss lawsuits brought against
asbestos manufacturers and other defendants by nonresident plaintiffs, the
majority of which could simply bring their lawsuits in the jurisdictions
where they were sold the allegedly defective products. At the very least,

Id. at *6.
Id.
31 Rios, 2020 WL 2963318, at *7.
32 See generally Economic Benefits of Tort Reform: An Assessment of Excessive Tort Costs in
Illinois and Potential Economic Benefits of Reform, THE PERRYMAN GROUP (Nov. 2019),
https://d3n8a8pro7vhmx.cloudfront.net/cala/pages/67/attachments/original/1582657304/C
ALA_Tort_Reform_Impact_IL_Report.pdf?1582657304.
33Ann Maher, Bayer Ruling an Important Check on Greed and Fairness of Courts, Asbestos
Reform Lawyer Says, MADISON – ST. CLAIR RECORD (Jun. 8, 2020),
https://madisonrecord.com/stories/539217528-bayer-ruling-an-important-check-on-greedand-fairness-of-courts-asbestos-reform-lawyer-says.
29
30
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Rios is one arrow in the quiver of defendants with deep enough pockets to
litigate personal jurisdiction.
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